|
Delayed
NYSE
17:09:14 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1751 USD | -1.07% |
|
+6.06% | -70.12% |
| 08-20 | Top Premarket Decliners | MT |
| 08-13 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| MTNB | Delayed | |
CBOE
| MTNB | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.2 | 0.332 | 0.5 |
| Spread/Res. | -12.45% | -47.26% | -64.98% |
| Spread/Supp. | +9.44% | +9.44% | +9.16% |
| Support | 0.16 | 0.16 | 0.1604 |
- Stock Market
- Stocks
- MTNB Stock
- Charts Matinas BioPharma
Select your edition
All financial news and data tailored to specific country editions
